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EDITORIAL

Ambulatory Blood Pressure Monitoring: Mercury
Rising

I

n this issue of Advances of Chronic Kidney Disease, the 3
coeditors, Debbie Cohen, Jesse Goldman, and John
Sim, have marshaled the efforts of 11 sets of authors to provide the readership with updates of the diagnosis and
management of the most prevalent cardiovascular disease,
hypertension. The 11 articles expansively cover the
engaging and multidimensional relationship between hypertension and the kidney. However, this editorial will
reﬂect on some of the vagaries encountered in the dayto-day practice of managing hypertension.
This brief vignette underscores the importance of developing and implementing blood pressure follow-up
protocols with involved stakeholders and the utility of
home-based blood pressure monitoring. An older man
with a 30-year history of high blood pressure had, in his
words, “been well controlled” by a 3-drug antihypertensive
regimen until recently. However, 7 weeks after an abdominal
surgery, his blood pressure, which had only been measured
sporadically, was recorded as 198/105 mmHg, and he had a
global headache. At 4 weeks postoperatively, his blood pressure had been recorded as normal. Notably, he had been taking only 1 antihypertensive agent then, amlodipine.
Losartan and hydrochlorothiazide had been discontinued
after surgery because of postoperative normotension. After
restarting these, his blood pressure descended into the
normal range over the next 4 weeks, while a hypertension
specialist followed his case closely and communicated with
the patient frequently. Over the next 5 to 6 weeks, the patient
engaged in home blood pressure monitoring after the appropriate method of blood pressure measurement was taught to
the patient. Three, 5-day blood pressure logs were submitted
to the specialist as a surrogate of ambulatory blood pressure
monitoring (ABPM). The 5-day blood pressure logs documented 4 blood pressures daily, 2 in the morning and 2 in
the evening, following measurements with an oscillometric
device that had been calibrated against an in-ofﬁce aneroid
device.1 Over 4 weeks, the blood pressure logs revealed a
decline in the patient’s blood pressure to normal level but
an absence of the normal decline in blood pressure during
the evening and night (Table 1).
Recently, the US Preventive Services Task Force issued the
following statement after conducting an exhaustive system-

atic review, funded by the Agency for Healthcare Research
and Quality, regarding the beneﬁts and harms of screening
adults for hypertension: “On the basis of the prognostic evidence, we selected ABPM as the reference standard for BP
measurement and for evaluating the diagnostic accuracy
of other measurement methods.2 We regarded daytime,
night-time, or 24-hour ABPM protocols as acceptable.”
This statement has broad implications because noninvasive
24-hour ABPM is not routinely carried out in the United
States or anywhere else for that matter, although it was
conceived of nearly 50 years ago by a team led by Sokolow3,4
and shown to correlate better than conventional mercurybased sphygmomanometry with blood pressure in the
elderly patient.5 The singular impediment in a fee-forservice environment is simply that the cost of the equipment
and time to properly perform ABPM represents a nearly nil
return on the investment of several thousand dollars of
equipment and computers. There are deﬁned American
Medical Association Current Procedural Terminology
billing codes for ABPM (93,784 and 93,788), but the only
indication is for Medicare beneﬁciaries with an International
Classiﬁcation of Diseases, Ninth Revision, Clinical Modiﬁcation
code 796.2/code R03.0 that signiﬁes an “elevated blood pressure reading without a diagnosis of hypertension,” which
roughly translates to “suspected ‘white coat hypertension
(WCH).’”6 Strictly, WCH is deﬁned operationally: (1)
clinic/ofﬁce blood pressure greater than 140/90 mmHg on
at least 3 separate clinic/ofﬁce visits with 2 separate measurements made at each visit, (2) at least 2 documented separate blood pressure measurements taken outside the clinic/
ofﬁce that are less than 140/90 mmHg, and (3) no evidence of
end-organ damage. The trouble with this concept is that it
omits individuals with “white coat effect,” namely a hypertensive individual who manifests blood pressure elevations
in-ofﬁce for whichever reason.7 Moreover, if ABPM must be
repeated, the qualifying criteria must be repeated. A full
24 hours of blood pressure measurements that encompass
Ó 2015 by the National Kidney Foundation, Inc. All rights reserved.
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Table 1. A 5-Day, Self-recorded Blood Pressure Log
AM
Day

SBP (mmHg)

1
2
3
4
5
Mean BP or HR
Min BP or HR
Max BP or HR
SD BP or HR

118
135
126
131
123
131
134
116
124
122
126.0
116.0
135.0
6.2

PM

DBP (mmHg)

HR (bpm)

SBP (mmHg)

DBP (mmHg)

HR (bpm)

95
82
82
78
85
81
87
78
82
76
82.6
76.0
95.0
5.2

82
82
82
78
85
67
84
76
75
73
78.4
67.0
85.0
5.4

147
149
152
119
145
134
148
118
130
121
136.3
118.0
152.0
12.8

92
89
90
82
87
82
87
77
88
79
85.3
77.0
92.0
4.7

76
72
71
76
78
72
65
74
83
84
75.1
65.0
84.0
5.4

Abbreviations: DBP, diastolic blood pressure; HR, heart rate; Max, maximum; Min, minimum; SBP, systolic blood pressure; SD, standard deviation.
Seated, right arm blood pressures were obtained during 2 intervals: twice from 0700 to 1000 hours (daytime) and twice from 1900 to
2200 hours (night-time). Means, minima, maxima, and SDs (measure of variability) were computed for SBP and DBP and HR during daytime
and night-time intervals.

daytime and night-time blood pressures must be ascertained from the recording device to obtain any reimbursement for conduct of the study.
For non-Medicare patients, few practitioners have bothered to petition third-party payers for reimbursement of
ABPM, and fewer of these payers have done so. To rub
salt into the wound, the reimbursement is generally
disproportionately smaller than what would be anticipated, given the effort entailed to properly read and interpret an ABPM study. The interpretation of ABPM
recordings is detailed and must be correlated with the
well-kept diary of the putatively hypertensive patient.
ABPM interpretation is generally not taught within the
curricula of Internal Medicine, Cardiology, Endocrinology, or Nephrology centers simply because there is
nothing to teach from. However, ABPM is carried out
routinely, and proper interpretation thereof takes place
within the rubric of dedicated hypertension fellowships.
If universally applied, ABPM deﬁnes and reﬁnes the
management of 4 groups of patients—Group 1: those
who manifested transient hypertension; Group 2: those
who incur WCH; Group 3: those who have hypertension;
and Group 4: those who have “masked” hypertension
(also referred to as isolated ambulatory hypertension:
normal ofﬁce-based blood pressure and elevated blood
pressure elsewhere)—undiagnosable in the absence of
ABPM. However, some cases of masked hypertension are
attributable to nocturnal hypertension (nocturnal systolic
blood pressure .120 mmHg).8 The utility of ABPM in
groups 1 and 2 is that individuals will not be inappropriately labeled or treated as having high blood pressure.
Ironically, this would be one of the few times that medication nonadherence would be of beneﬁt. Group 3 hypertensives who faithfully reproduce perfect blood pressure
records yet truly have high blood pressure will have their
hypertension exposed by ABPM. These patients mask their
hypertension but do not have the masked hypertension of
Group 4, deﬁned as hypertension by ABPM or home blood

pressure monitoring with normal ofﬁce-based blood pressures. This phenomenon occurs in approximately 12% to
14% of those with normal ofﬁce-based blood pressures
and who are not treated as hypertensive patients. Masked
hypertension has been correlated with left ventricular hypertrophy, increased carotid artery intima thickness, and
decreased large artery distensibility. Cardiovascular disease risk may be equivalent to patients with conventional
ofﬁce-based hypertension. A person with a home blood
pressure log that reveals masked hypertension should
likely undergo a 24-hour blood pressure recording, to optimize their medical management. Lastly, masked hypertension should be sought out in patients with diabetes and/or
CKD and treated accordingly.
ABPM as a monitoring tool is valuable. In the 6-month,
419 participant, treatment-blinded, Belgian Ambulatory
Blood Pressure Monitoring and Treatment of Hypertension
study, the hypothesis that ABPM vs conventional blood
pressure measurement would result in less intensive antihypertensive therapy was fulﬁlled.9 Brieﬂy, total medication discontinuation was achieved in 26.3% of those
randomized to the ABPM-monitored group vs only 7.3%
(P , .001) in conventional, ofﬁce-based group.9 In the control group, 42.7% progressed to sustained multiple agent
therapy vs just 27.2% in the ABPM-monitored group
(P , .001). ABPM may be of particular utility in elderly patients in whom high pulse pressures correspond to
impaired diastolic coronary artery ﬁlling and reduced
cerebral perfusion. Overly aggressive antihypertensive
therapy, which is discoverable by ABPM, can thus be
identiﬁed and remediated. This risk potential has been at
least partially attenuated by the global change of the hypertensive systolic pressure threshold to 150 mmHg for elderly
persons by Recommendation 1 of the Eighth Joint National
Committee’s 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults.10
ABPM reporting includes facets of the blood pressure
that are ignored in routine practice: circadian variation,
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integrated blood pressure load, and variability of blood
pressure. One of these is “dipper” status. Within the circadian rhythm of most patients, an evening-to-nocturnal
“physiological” blood pressure reduction transpires.11,12
Those who manifest this unprovoked blood pressure
reduction that is normally 10% or more of the daytime
systolic and diastolic blood pressures are termed, dippers.
Those who do not are “nondippers” and have worse
cardiovascular outcomes than their dipping counterparts,
presumably from elevated nocturnal sympathetic nervous
system tone. Nondippers, representing 10% to 40% of
individuals who have undergone ABPM in blood pressure
trials, demonstrate more left ventricular hypertrophy,
brain lacunae, albuminuria, and cardiovascular mortality
than dippers.13-21
Although, the nocturnal dipping status of systolic and
diastolic blood pressures is evaluated in ABPM, the systolic pressure appears the more important of the two
and overrides any effects of the 24-hour blood pressure.
The hazard rate for total cardiovascular events was 1.41
(95% conﬁdence interval, 1.03 to 1.94, P ¼ .03) in the Systolic Hypertension in Europe study for each 10% increment of night-to-day systolic blood pressure.22 In this
808-patient trial of isolated systolic hypertension with a
median follow-up of 4.4 years, 12% of participants developed a major cardiovascular-related event. ABPM disclosed that increased night-time systolic pressures
associated with these events; the hazard rate for cerebrovascular events increased by 0.31 and 0.20 for cardiovascular events for each 10 mmHg increment of systolic
pressure. A nocturnal blood pressure of 142 mmHg was
equivalent to a daytime blood pressure of 160 mmHg.
This increased burden of cardiovascular disease risk was
also apparent in an ambulatory, rural Japanese population
and an Italian prospective registry of cardiovascular
morbidity and mortality. The Ohasama Study followed
1300 participants aged 20 years or more for 5 years.23
Those nondippers whose 24-hour systolic pressures appeared in the highest quintile developed a signiﬁcant
2.56-fold enhancement of cardiovascular mortality over
the study’s dippers. Equally compelling evidence has
not yet been shown in blacks or patients with CKD who
fail to follow a normal circadian blood pressure pattern.
Lastly, nondipping may disclose a secondary source of hypertension such as sleep apnea, which our patient had,
and that is characterized by enhanced sympathetic activity.24 Kimura strongly argues that loss of dipping status
is often representative of kidney disease in the absence
of secondary hypertension.
A rectangle of width W and height H is certainly smaller
than one of 3 W and 0.75 H, but we do not think of blood
pressure in such an integrated manner. However, the
concept of blood pressure load25 is inculcated into
ABPM, and only ABPM calculates this otherwise uncalculated entity when a sufﬁcient number of blood pressures
have been obtained (minima: 14 daytime and 7 nighttime blood pressures). The blood pressure load is deﬁned
by determining the number/proportion of blood pressures
that exceed the hypertension threshold pressures during
the daytime and night-time intervals.26 The blood pressure load associates with left ventricular hypertrophy,
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especially if the systolic and diastolic blood pressure loads
exceed 50% or 70%, respectively.
Greater blood pressure variability has been touted by
some to predict target organ damage. The variability
parameter is self-consciously reported by patients who
proclaim how much their blood pressure “jumps
around,” notwithstanding that the patients themselves
may have been jumping around during blood pressure
measurements. Formally deﬁned as the standard deviation of the systolic pressure, daytime or night-time above
a group mean, blood pressure variability is not reported
by all investigators. Conﬂicting results regarding this
metric’s usability and clinical utility preclude its use in
an evidence-based fashion at this time.27 For now, until
further results are forthcoming, blood pressure variability’s clinical utility is for want of a better word, variable.
However, the 24-hour ABPM-based pulse pressure is
predictive of cardiovascular and cerebrovascular events.
This metric of arterial stiffness was examined by ofﬁcebased blood pressure measurement and ABPM over a
mean 3.8 years of follow-up in the Progetto Ipertensione
Umbria Monitoraggio Ambulatoriale study, with cardiovascular morbidity and mortality as end points.28 Ambulatory pulse pressure clearly portended cardiovascular
morbidity and mortality more than age, left ventricular
hypertrophy, and nondipper status. Notably, ABPMbased pulse pressure was minimally more valuable than
ofﬁce-based pulse pressure, implying that the diagnosis
of arterial inelasticity at a certain threshold by any blood
pressure measuring technique is associated with greater
cardiovascular disease.
Lastly, ABPM may lower the total cost of antihypertensive
care. This is in direct alignment with the Affordable Care
Act, although ABPM, which costs approximately $100 to
$350 per measurement,29 has been considered too expensive by the majority of the payers for the reasons cited
earlier and cost neutral by others. For example, ofﬁce visits
for hypertension can be greatly reduced by ABPM, which
represents an amortized piece of equipment, a clear cost
savings over time for each hypertensive patient. Overall,
medication costs were decreased in toto by ABPM with
respect to population-based hypertension management.9,30
In the Ambulatory Blood Pressure Monitoring and
Treatment of Hypertension trial, the ABPM arm saved
nearly $8 less on blood pressure medications per patient
per month ($4188 vs $3390 per 100 patients per month),
and physician visits were decreased. If this calculus is
further veriﬁed, then arguably, most physicians would
only be involved during escalation of care of hypertensive
individuals, ie, prescription of second and third drugs to
patients with essential hypertension.
It is time for medical personnel to stop taking blood
pressures on patients when possible. This is especially
relevant because a great number of blood pressures are acquired errantly for multiple reasons including the use of
noncalibrated aneroid devices and failure to position patients and measuring devices appropriately for blood
pressure measurements. And physicians generally should
not be taking any patient’s blood pressure in the majority
of circumstances. Mounting evidence clearly shows that
physicians, nurses, and other health care workers should
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not be obtaining ofﬁce-based blood pressures from patients. Aside from the patient, the blood pressure
measuring device and a quiet room, devoid of television,
telephones, reading materials, and other persons (ie, family members), are all that is necessary to obtain the blood
pressure. Auto-repeated measurements are useful using
standard oscillometrically based equipment and must
become the norm at home.31,32 It follows logically that
the patient must take ownership of his blood pressure
and measure it in a protocolized fashion, particularly
after a signiﬁcant health-related event such as our patient
experienced. Until ABPM is widely deployed and to
rectify the problem of inaccurate blood pressure measurement, retraining of all medical personnel is required. To
this end, initiatives such as the American Medical Group
Foundation’s national effort to combat high blood pressure, the Measure Up/Pressure Down campaign, is
laudable and achievable.33 The Foundation has enjoined
over 140 medical groups of the American Medical Group
Association, representing 42 million patients, in their
effort to effect successful antihypertensive therapy.
Leveraging multiple stakeholders who develop highquality best practice tools that engage providers and patients in co-ordinated care delivery systems is anticipated
to successfully treat 80% of antihypertensive patients to
their respective goals. In essence, high blood pressure is
everyone’s problem and everyone must be involved in
the solution. The resolution to this problem clearly involves greater implementation of ABPM, which facilitates
the diagnosis of those individuals who are truly hypertensive and permits more facile monitoring of them. Until
then, continue to educate your patients on the proper
method for them to participate in home blood pressure
monitoring as our patient did. Home blood pressure
monitoring is roughly equivalent to a 24-hour ABPM
study and considered especially useful in diabetics,
pregnant women, children, and individuals with CKD.34
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The most familiar precepts are not always the truest.
—MP
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